Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Vivani Medical, Inc.NASDAQ: VANI
Operating Expenses · Q1 FY2026 · quarter ended Mar 2026
Operating expenses grows, but more slowly than its trailing trend
Q1 FY2026 operating expenses of $6.69M rose 2.0% year over year, behind the +11.1% change in trailing-twelve-month operating expenses. Sequentially, it fell 1.8% from the prior quarter. Over 3 fiscal years it compounded at +8.5% a year.
Context
- Operating expenses increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +2.0% toward the trailing-twelve-month pace of +11.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 27.13M USD
- Year-over-year change
- +9.9%
- 4-year CAGR
- +19.5%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 27.13M | +9.9% |
| FY2024 | 2024-12-31 | 24.68M | -7.3% |
| FY2023 | 2023-12-31 | 26.61M | +25.3% |
| FY2022 | 2022-12-31 | 21.24M | +59.4% |
| FY2021 | 2021-12-31 | 13.32M | — |
Operating Expenses vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +11.1% is the 3rd highest of 8, against a peer median of +1.4%.
- Over three fiscal years its annual growth of +8.5% compares with a peer median of +4.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $98.38M USD | -12.5% | +21.7% | 136.0% | |
IMAImageneBio Inc | LTM Mar 2026 | $55.15M USD | +53.1% | +29.5% | — |
| LTM Mar 2026 | $42.59M USD | -12.9% | -16.3% | 277.8% | |
| LTM Mar 2026 | CA$35.59M CAD | +1.4% | +4.2% | — | |
| LTM Mar 2026 | $32.88M USD | +8.0% | +7.8% | 31.2% | |
| LTM Mar 2026 | $27.68M USD | +11.1% | +8.5% | — | |
| LTM Mar 2026 | $16.03M USD | +31.0% | +3.5% | 15268.6% | |
| LTM Mar 2026 | $14.22M USD | -0.8% | -29.6% | — | |
| Peer median (excluding VANI) | — | +1.4% | +4.2% | 206.9% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 357K | 0 | 424K |
| Gross Profit | 0 | 0 | (357K) | 0 | (424K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 11M | 14.17M | 16.97M | 15.75M | 18.13M |
| Selling, General & Admin | 2.32M | 5.37M | 10M | 8.93M | 9.43M |
| Operating Expenses | 13.32M | 21.24M | 26.61M | 24.68M | 27.13M |
| Depreciation & Amortization | 345K | 381K | 357K | 400K | 424K |
| EBITDA | (12.43M) | (19.16M) | (25.3M) | (23.09M) | (26.19M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (13.32M) | (21.24M) | (26.97M) | (24.68M) | (27.56M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 550K | 7.35M | 1.31M | 1.19M | 947K |
| Income Before Tax | (12.77M) | (13.89M) | (25.65M) | (23.49M) | (26.61M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (12.77M) | (13.89M) | (25.65M) | (23.49M) | (26.61M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (0.33) | (0.17) | (0.50) | (0.43) | (0.43) |
| EPS (Diluted) | (0.33) | (0.17) | (0.50) | (0.43) | (0.43) |
| Weighted Avg Shares | 36.25M | 38.24M | 50.85M | 54.98M | 62.39M |
| Weighted Avg Shares (Diluted) | 36.25M | 38.24M | 50.85M | 54.98M | 62.39M |
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.